Evidence map›Paper›PMID 32856419›Full record

ArticleAging cell2020

Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.

Brandon M Hall, Anatoli S Gleiberman, Evguenia Strom, Peter A Krasnov, David Frescas, Slavoljub Vujcic, Olga V Leontieva, Marina P Antoch, Valeria Kogan, Igor E Koman and 5 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. VSIG4Journal of experimental & clinical cancer research : CR · 2025
    Article
  7. Article
  8. Immunoregulation in cancer-associated cachexia.Journal of advanced research · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Functional genomics of inflamm-aging and immunosenescence.Briefings in functional genomics · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Brandon M HallEveron Biosciences Inc, Buffalo, NY, USA.
Anatoli S GleibermanEveron Biosciences Inc, Buffalo, NY, USA.
Evguenia StromEveron Biosciences Inc, Buffalo, NY, USA.
Peter A KrasnovEveron Biosciences Inc, Buffalo, NY, USA.
David FrescasEveron Biosciences Inc, Buffalo, NY, USA.
Slavoljub VujcicEveron Biosciences Inc, Buffalo, NY, USA.
Olga V LeontievaDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Marina P AntochDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Valeria KoganInstitute for Translational Research, Ariel University, Ariel, Israel.
Igor E KomanInstitute for Translational Research, Ariel University, Ariel, Israel.
Yi ZhuRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Tamara TchkoniaRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
James L KirklandRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Olga B ChernovaEveron Biosciences Inc, Buffalo, NY, USA.
Andrei V GudkovEveron Biosciences Inc, Buffalo, NY, USA.ORCID 0000-0003-2548-0154
Abcombi Biosciences (United States) · USMayo Clinic in Florida · USRoswell Park Comprehensive Cancer Center · USAriel University · IL

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CANDACE S JOHNSON · 1985 to 2026
$116.6M
Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla, Nathan K LeBrasseur · 2019 to 2026
$28.7M
NCI NIH HHS P30 CA016056NIA NIH HHS P01 AG062413
6 · The paper itself

Abstract

Adipose tissue is recognized as a major source of systemic inflammation with age, driving age-related tissue dysfunction and pathogenesis. Macrophages (Mφ) are central to these changes yet adipose tissue Mφ (ATMs) from aged mice remain poorly characterized. To identify biomarkers underlying changes in aged adipose tissue, we performed an unbiased RNA-seq analysis of ATMs from young (8-week-old) and healthy aged (80-week-old) mice. One of the genes identified, V-set immunoglobulin-domain-containing 4 (VSIG4/CRIg), encodes a Mφ-associated complement receptor and B7 family-related immune checkpoint protein. Here, we demonstrate that Vsig4 expression is highly upregulated with age in perigonadal white adipose tissue (gWAT) in two mouse strains (inbred C57BL/6J and outbred NIH Swiss) independent of gender. The accumulation of VSIG4 was mainly attributed to a fourfold increase in the proportion of VSIG4

Indexed as

Adipose Tissue, WhiteAgingAnimalsBiomarkersFemaleMacrophagesMaleMiceMice, Inbred C57BLReceptors, ComplementBiomarkersReceptors, ComplementVSIG4 protein, mouseadipose tissueagingfrailty indeximmune checkpointinflammationmacrophagemouseVSIG4

Identifiers

PMID32856419
PMCPMC7576241
OpenAlexW3082525692

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.